Aptinyx Inc reported $48.79M in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Acorda Therapeutics ACOR:US USD 75.77M 12.14M
Biogen BIIB:US USD 12.78B 903M
Cara Therapeutics CARA:US USD 184.82M 19.6M
Daiichi Sankyo 4568:JP JPY 1.47T 66.9B
Eli Lilly And LLY:US USD 10.07B 1.53B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Intra Cellular Therapies ITCI:US USD 685.42M 36.78M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Marinus Pharmaceuticals MRNS:US USD 82M 77.2M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B